Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Streptococcus pyogenes serotype M1 | Streptokinase A | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | transcription factor btf3 | 0.0042 | 0.2652 | 0.4189 |
Brugia malayi | MH2 domain containing protein | 0.001 | 0.0316 | 0.0316 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.0086 | 0.5792 | 0.9821 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.0087 | 0.5892 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.001 | 0.0316 | 0.0316 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 1 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.0086 | 0.5792 | 0.9821 |
Brugia malayi | MH1 domain containing protein | 0.001 | 0.0316 | 0.0316 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0042 | 0.2652 | 0.5 |
Trypanosoma brucei | transcription factor BTF3, putative | 0.0042 | 0.2652 | 0.5 |
Echinococcus granulosus | transcription factor btf3 | 0.0042 | 0.2652 | 0.4189 |
Brugia malayi | beta-NAC-like protein | 0.0042 | 0.2652 | 0.2652 |
Trypanosoma cruzi | transcription factor btf3, putative | 0.0042 | 0.2652 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0042 | 0.2652 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0042 | 0.2652 | 0.5 |
Loa Loa (eye worm) | Smad1 | 0.001 | 0.0316 | 0.0316 |
Brugia malayi | Protein kinase domain containing protein | 0.0087 | 0.5892 | 0.5892 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.001 | 0.0316 | 0.0316 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.0086 | 0.5792 | 0.9821 |
Plasmodium vivax | basic transcription factor 3b, putative | 0.0042 | 0.2652 | 0.5 |
Brugia malayi | MH1 domain containing protein | 0.001 | 0.0316 | 0.0316 |
Brugia malayi | MH2 domain containing protein | 0.001 | 0.0316 | 0.0316 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0042 | 0.2652 | 0.5 |
Loa Loa (eye worm) | ICD-1 protein | 0.0042 | 0.2652 | 0.2652 |
Echinococcus granulosus | 3'partial|mitogen activated protein kinase kinase kinase | 0.0086 | 0.5792 | 0.9821 |
Schistosoma mansoni | transcription factor btf3 | 0.0042 | 0.2652 | 1 |
Loa Loa (eye worm) | TKL/MLK/TAK1 protein kinase | 0.0087 | 0.5892 | 0.5892 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase 7 | 0.0086 | 0.5792 | 0.9821 |
Echinococcus granulosus | mitogen activated protein kinase kinase kinase | 0.0087 | 0.5892 | 1 |
Brugia malayi | Smad1 | 0.001 | 0.0316 | 0.0316 |
Echinococcus multilocularis | kinase protein | 0.0086 | 0.5792 | 0.9821 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 1 | 1 |
Entamoeba histolytica | transcription factor BTF3, putative | 0.0042 | 0.2652 | 0.5 |
Echinococcus granulosus | 5'partial|3'partial|mitogen activated protein kinase kinase kinase | 0.0086 | 0.5792 | 0.9821 |
Toxoplasma gondii | NAC domain-containing protein | 0.0042 | 0.2652 | 0.5 |
Plasmodium falciparum | basic transcription factor 3b, putative | 0.0042 | 0.2652 | 0.5 |
Echinococcus multilocularis | kinase protein | 0.0086 | 0.5792 | 0.9821 |
Leishmania major | basic transcription factor 3a, putative | 0.0042 | 0.2652 | 0.5 |
Trypanosoma cruzi | transcription factor btf3, putative | 0.0042 | 0.2652 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 6.057 um | PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1662 (Primary HTS)] | ChEMBL. | No reference |
EC50 (functional) | = 34.175 um | PUBCHEM_BIOASSAY: Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1902 (Retest at Dose), 1900 (Counter Screen), 1662 (Primary HTS)] | ChEMBL. | No reference |
Potency (functional) | 0.1122 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.